PAVmed Inc.
NASDAQ Capital MarketTotal Valuation
PAVmed Inc. carries a market capitalization of 769,747.00, placing it among publicly traded companies globally. Its enterprise value stands at 82.99M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 769,747.00 |
| Enterprise Value | 82.99M |
Share Statistics
PAVmed Inc. currently has 9.43M shares outstanding.
| Shares Outstanding | 9.43M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Enterprise Valuation
| EV / Sales | 21.67 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
PAVmed Inc. maintains a current ratio of 0.57, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -268.39, indicating conservative leverage, while an interest coverage ratio of -279.42 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.57 |
| Quick Ratio | 0.48 |
| Debt / Equity | -268.39 |
| Debt / EBITDA | -0.87 |
| Interest Coverage | -279.42 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -124.06 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 11.09 |
Stock Price Statistics
PAVmed Inc.'s stock has gained approximately 0% over the past 52 weeks. The 50-day moving average sits at 0.21, while the 200-day moving average is 1.66.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 0.21 |
| 200-Day Moving Average | 1.66 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -57.28M, while operating income came in at -59.63M.
| Revenue | 3.83M |
| Gross Profit | -2.97M |
| Operating Income | -59.63M |
| Pretax Income | -72.58M |
| Net Income | -57.75M |
| EBITDA | -57.28M |
| EBIT | -59.63M |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
PAVmed Inc. holds 25.50M in cash and equivalents against 50.03M in total debt, resulting in a net debt position of 18.50M. Total book value stands at -320.62M, with working capital of -23.18M providing operational flexibility.
| Cash & Cash Equivalents | 25.50M |
| Total Debt | 50.03M |
| Net Debt | 18.50M |
| Equity (Book Value) | -320.62M |
| Book Value Per Share | N/A |
| Working Capital | -23.18M |
Cash Flow
PAVmed Inc. produced -47.73M in operating cash flow over the past twelve months.
| Operating Cash Flow | -47.73M |
| Capital Expenditures | -246,000.00 |
| Free Cash Flow | -47.97M |
| FCF Per Share | N/A |
Margins
PAVmed Inc. operates with a gross margin of -77.59, reflecting its pricing power and cost economics. The operating margin of -1,557.35 and net profit margin of -1,508.12 provide insight into operational efficiency.
| Gross Margin | -77.59 |
| Operating Margin | -1,557.35 |
| Pretax Margin | -1,895.64 |
| Profit Margin | -1,508.12 |
| EBITDA Margin | -1,496.00 |
Dividends & Yields
The company's payout ratio of 8.20 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | 8.20 |
| Shareholder Yield | N/A |
| FCF Yield | N/A |
Scores
PAVmed Inc. posts an Altman Z-Score of -17.41, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -17.41 |